A record of what Choice Institutional Equities Analysis said publicly, with the source. Not advice.
“Maintains a 'Buy' rating on Laurus Labs with a target price of ₹1,085, based on the company's strategic shift towards a CDMO (Synthesis)-led model, which is expected to contribute over 30% to revenues in the medium term. Margins are projected to expand to 23–25% due to a favorable product mix and high-margin CDMO business, justifying the 50x FY27-28 EPS valuation.”
Choice Institutional Equities Analysis’s track record (trackable calls only): 77 graded calls · 95% CI 35–57%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
No entry price is stated, so the call starts at the first close after it was published.
Target ₹1,085, as stated.
Window: 90 days, from the call's own horizon word ("in the medium term").
The target ₹1,085 was reached on a close. Hit.
The grader’s working: R4 TARGET_CALL: entered ₹940.15 on 2025-10-27 (next trading session's close); target ₹1085 reached at close ₹1085 on 2025-12-26. Window 90 days — rule H4: the quote says "in the medium term" (short-term 30 days, medium-term 90, long-term 12 months).
How it played out
How this is worked out- Time to target
- The target was reached on a close 42 trading sessions (60 calendar days) after the entry.
- Worst close against it
- No close was ever against the call before the target was reached. Closing prices only; an intraday dip is never counted.
From the entry the grade used, on closing prices. This is a record of one past call and is not advice.